keyword
https://read.qxmd.com/read/38717047/microfluidics-based-egfr-mutation-detection-and-its-implication-in-the-resource-limited-clinical-setting
#21
JOURNAL ARTICLE
Pradnya Joshi, Prachi Gogte, Trupti Pai, Mamta Gurav, Dipika Dhanawade, Nupur Karnik, Gauri Deshpande, Rajiv Kaushal, Omshree Shetty
Management of lung cancer today obligates a mutational analysis of the epidermal growth factor receptor (EGFR) gene particularly when Tyrosine Kinase Inhibitor (TKI) therapy is being considered as part of prognostic stratification. This study evaluates the performance of automated microfluidics-based EGFR mutation detection and its significance in clinical diagnostic settings. Formalin-fixed, paraffin-embedded (FFPE) samples from NSCLC patients (n = 174) were included in a two-phase study. Phase I: Validation of the platform by comparing the results with conventional real-time PCR and next-generation sequencing (NGS) platform...
May 8, 2024: International Journal of Experimental Pathology
https://read.qxmd.com/read/38716680/microfluidic-immunosensor-platform-for-sensitive-detection-of-human-epidermal-growth-factor-receptor-2-based-on-enhanced-cathode-electrochemiluminescence-of-bimetallic-nanoclusters
#22
JOURNAL ARTICLE
Xuening Liu, Xiaoyue Zhang, Rui Feng, Xiang Ren, Dan Wu, Xuejing Liu, Lei Liu, Qin Wei
In this work, a microfluidic immunosensor chip was developed by incorporating microfluidic technology with electrochemiluminescence (ECL) for sensitive detection of human epidermal growth factor receptor-2 (HER2). The immunosensor chip can achieve robust reproducibility in mass production by integrating multiple detection units in a series. Notably, nanoscale materials can be better adapted to microfluidic systems, greatly enhancing the accuracy of the immunosensor chip. Ag@Au NCs closed by glutathione (GSH) were introduced in the ECL microfluidic immunosensor system with excellent and stable ECL performance...
May 8, 2024: Analytical Chemistry
https://read.qxmd.com/read/38716480/prognostic-value-of-pathological-nodal-burden-after-neoadjuvant-chemotherapy-in-initially-cn0-1-breast-cancer-patients-a-dual-center-10-year-survival-analysis
#23
JOURNAL ARTICLE
Amina Maimaitiaili, Zhimin Fan, Jingyi Zhang, Yidi Wang, Bohui Shi, Jie Zheng, Gefei Li, Yuting Zhao, Shengyu Pu, Jianjun He, Fengjiang Qu, Huimin Zhang
BACKGROUND: There is an interest in performing de-escalating axillary surgery after neoadjuvant chemotherapy (NAC). However, the significance of residual axillary node disease after NAC has not been well studied. OBJECTIVES: To investigate the pathological residual axillary lymph node tumor burden (ypN) of patients with initial clinical nodal stage cN0-1 breast cancer after NAC and determine its prognostic value. DESIGN: Initial cN0-1 breast cancer patients who received NAC followed by axillary surgery at the First Hospital of Jilin University and the First Affiliated Hospital of Xi'an Jiaotong University between January 2011 and December 2019 were included...
2024: Therapeutic Advances in Medical Oncology
https://read.qxmd.com/read/38715141/circhif1a-induces-cetuximab-resistance-in-colorectal-cancer-by-promoting-hif1%C3%AE-mediated-glycometabolism-alteration
#24
JOURNAL ARTICLE
Yiting Geng, Xiao Zheng, Dachuan Zhang, Shanshan Wei, Jun Feng, Wei Wang, Luo Zhang, Changping Wu, Wenwei Hu
Epidermal growth factor receptor (EGFR)-targeted therapy is an important treatment for RAS wild-type metastatic colorectal cancer (mCRC), but the resistance mechanism remains unclear. Here, the differential expression of circRNAs between Cetuximab sensitive and resistant cell lines was analyzed using whole-transcriptome sequencing. We identified that the expression of circHIF1A was significantly higher in LIM1215-R than in LIM1215. When treated with Cetuximab, downregulation of circHIF1A level weakened the proliferation and clonal formation ability of LIM1215-R, caused more cells to enter G0-G1 phase, and significantly reduced the basal respiration, ATP production, and maximal respiration, as well as the glycolytic capacity and glycolytic reserve...
May 7, 2024: Biology Direct
https://read.qxmd.com/read/38713650/-s-blebbistatin-o-benzoate-has-the-potential-to-improve-atopic-dermatitis-symptoms-in-nc-nga-mice-by-upregulating-epidermal-barrier-function-and-inhibiting-type-2-alarmin-cytokine-induction
#25
JOURNAL ARTICLE
Shunya Sahara, Ayumi Ueno, Natsuki Wakita, Miki Iwai, Junki Uda, Koich Nakaoji, Kazuhiko Hamada, Akito Maeda, Yasufumi Kaneda, Manabu Fujimoto
Atopic dermatitis is a multi-pathogenic disease characterized by chronic skin inflammation and barrier dysfunction. Therefore, improving the skin's ability to form an epidermal barrier and suppressing the production of cytokines that induce type 2 inflammatory responses are important for controlling atopic dermatitis symptoms. (-)-Blebbistatin, a non-muscle myosin II inhibitor, has been suggested to improve pulmonary endothelial barrier function and control inflammation by suppressing immune cell migration; however, its efficacy in atopic dermatitis is unknown...
2024: PloS One
https://read.qxmd.com/read/38713612/graphegfr-multi-task-and-transfer-learning-based-on-molecular-graph-attention-mechanism-and-fingerprints-improving-inhibitor-bioactivity-prediction-for-egfr-family-proteins-on-data-scarcity
#26
JOURNAL ARTICLE
Bundit Boonyarit, Nattawin Yamprasert, Pawit Kaewnuratchadasorn, Jiramet Kinchakawat, Chanatkran Prommin, Thanyada Rungrotmongkol, Sarana Nutanong
The proteins within the human epidermal growth factor receptor (EGFR) family, members of the tyrosine kinase receptor family, play a pivotal role in the molecular mechanisms driving the development of various tumors. Tyrosine kinase inhibitors, key compounds in targeted therapy, encounter challenges in cancer treatment due to emerging drug resistance mutations. Consequently, machine learning has undergone significant evolution to address the challenges of cancer drug discovery related to EGFR family proteins...
May 7, 2024: Journal of Computational Chemistry
https://read.qxmd.com/read/38713311/cdk4-6-inhibitors-the-devil-is-in-the-detail
#27
REVIEW
Tara Magge, Sneha Rajendran, Adam M Brufsky, Julia Foldi
PURPOSE OF REVIEW: Update on the most recent clinical evidence on CDK4/6 inhibitors (CDK4/6i) in the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor (HER)2-negative breast cancer. RECENT FINDINGS: Over the past decade, CDK4/6i have become part of the standard of care treatment of patients with both metastatic and high-risk early HR + /HER2- breast cancers. The three available CDK4/6i (palbociclib, ribociclib and abemaciclib) have been extensively studied in combination with endocrine therapy (ET) in metastatic breast cancer (mBC) with consistent prolongation of progression free survival; however, ribociclib has emerged as the preferred first line agent in mBC given overall survival benefit over endocrine monotherapy...
May 7, 2024: Current Oncology Reports
https://read.qxmd.com/read/38713229/overexpressing-s100a9-ameliorates-nk-cell-dysfunction-in-estrogen-receptor-positive-breast-cancer
#28
JOURNAL ARTICLE
Yansong Liu, Mingcui Li, Zhengbo Fang, Shan Gao, Weilun Cheng, Yunqiang Duan, Xuelian Wang, Jianyuan Feng, Tianshui Yu, Jiarui Zhang, Ting Wang, Anbang Hu, Hanyu Zhang, Zhiyuan Rong, Suborna S Shakila, Yuhang Shang, Fanjing Kong, Jiangwei Liu, Yanling Li, Fei Ma
BACKGROUND: Estrogen receptor (ER) positive human epidermal growth factor receptor 2 (HER2) negative breast cancer (ER+/HER2-BC) and triple-negative breast cancer (TNBC) are two distinct breast cancer molecular subtypes, especially in tumor immune microenvironment (TIME). The TIME of TNBC is considered to be more inflammatory than that of ER+/HER2-BC. Natural killer (NK) cells are innate lymphocytes that play an important role of tumor eradication in TME. However, studies focusing on the different cell states of NK cells in breast cancer subtypes are still inadequate...
May 7, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38712728/oral-tranexamic-acid-treats-papulopustular-rosacea-by-improving-the-skin-barrier
#29
JOURNAL ARTICLE
Zining Xu, Biao Yu, Bingyang Xu, Shuhong Ye, Yuxin Qing, Bin Zhao, Sun Hong, Na Wu, Jiawen Wu
BACKGROUND: Papulopustular rosacea (PPR) is a chronic inflammatory disease with a significant impact on facial aesthetics. An impaired skin barrier is an important factor in the development and exacerbation of PPR. Tranexamic acid (TXA) has immune regulatory and anti-inflammatory effects, inhibits angiogenesis and endothelial hyperplasia, and promotes skin barrier repair. AIMS: We investigated the efficacy and safety of oral TXA for PPR treatment. PATIENTS/METHODS: In total, 70 patients were randomly assigned to receive traditional therapy plus oral TXA or traditional therapy alone for 8 weeks, with a 4-week follow-up period...
May 7, 2024: Journal of Cosmetic Dermatology
https://read.qxmd.com/read/38712314/successful-osimertinib-rechallenge-without-concomitant-corticosteroids-after-osimertinib-induced-pneumonitis
#30
Taisuke Ito, Kazuo Tsuchiya, Rie Mori, Takuro Akashi, Yoshiyuki Oyama, Masaki Ikeda
A 60-year-old woman was diagnosed with cT4N3M1c stage IVB lung adenocarcinoma with epidermal growth factor receptor mutation of exon19 deletion. After one month of treatment with osimertinib, a cough and diffuse ground glass opacities were observed in the bilateral lung field. Based on the clinical course and the exclusion of other etiologies, osimertinib-induced pneumonitis was diagnosed. The shadows resolved after osimertinib was discontinued. However, brain metastasis and leptomeningeal metastasis developed 20 months later; therefore, osimertinib was re-administered without concomitant corticosteroids...
2024: Respiratory Medicine Case Reports
https://read.qxmd.com/read/38712094/hair-follicles-modulate-skin-barrier-function
#31
Noah C Ford, Rachel E Benedeck, Matthew T Mattoon, Jamie K Peterson, Arlee L Mesler, Natalia A Veniaminova, Danielle J Gardon, Shih-Ying Tsai, Yoshikazu Uchida, Sunny Y Wong
Our skin provides a protective barrier that shields us from our environment. Barrier function is typically associated with interfollicular epidermis; however, whether hair follicles influence this process remains unclear. Here, we utilize a potent genetic tool to probe barrier function by conditionally ablating a quintessential epidermal barrier gene, Abca12 , which is mutated in the most severe skin barrier disease, harlequin ichthyosis. With this tool, we deduced 4 ways by which hair follicles modulate skin barrier function...
April 27, 2024: bioRxiv
https://read.qxmd.com/read/38711900/complete-response-after-treatment-of-breast-cancer-with-isolated-liver-metastasis-a-case-report
#32
Tingjian Zhang, Yuyao Liu, Lumeng Yang, Tian Tian
BACKGROUND: Breast cancer has a high incidence and is prone to metastasis, while isolated liver metastasis is rare. A growing body of evidence supports the effectiveness of treating breast cancer with anti-human epidermal growth factor receptor-2 (HER2) therapy in combination with chemotherapy. However, little is known about its impact on metastatic liver disease. There is also a lack of consensus on managing liver metastases from breast cancer, and no studies have been conducted on managing the disappearance of liver metastases after treatment...
2024: AME Case Reports
https://read.qxmd.com/read/38711384/incidence-and-survival-of-primary-metastatic-breast-cancer-in-denmark-implication-of-breast-cancer-screening-classification-and-staging-practice
#33
JOURNAL ARTICLE
Tobias Berg, Maj-Britt Jensen, Maria Rossing, Christian T Axelsen, Iben Kümler, Lise Søndergaard, Marianne Vogsen, Ann S Knoop, Bent Ejlertsen
BACKGROUND: Primary metastatic breast cancer (pMBC) accounts for 5-10% of annual breast cancers with a median survival of 3-4 years, varying among subtypes. In Denmark, the incidence of breast cancer increased until 2010, followed by a stabilisation. Several factors influencing pMBC incidence and survival, including screening prevalence, staging methods, and classification standards, remain pivotal but inadequately documented. MATERIAL AND METHOD: This retrospective observational study involving pMBC patients diagnosed between 2000 and 2020 encompassed all Danish oncology departments...
May 6, 2024: Acta Oncologica
https://read.qxmd.com/read/38711279/granular-c3-dermatosis-a-report-of-two-cases-and-a-mini-review-of-literature
#34
JOURNAL ARTICLE
Eriko Takayama, Saki Kuwahara, Akiko Yoshioka, Chiharu Tateishi, Takashi Hashimoto
Granular C3 dermatosis (GCD) is characterized by bullous, erythematous, and eczematous skin lesions similar to dermatitis herpetiformis, and granular deposition of complement C3 and C5b-9 along the epidermal basement membrane zone (BMZ) by direct immunofluorescence (IF). Here, we present two cases of GCD with different clinical features. Case 1, a 49-year-old man, showed pruritic blisters and erythema of the extremities. Case 2, a 53-year-old woman, showed severely pruritic papules, erythema, and erosions on the entire body with scattered blisters, mainly on the lower extremities...
May 6, 2024: Journal of Dermatology
https://read.qxmd.com/read/38711223/cldn1-knock-out-keratinocytes-as-a-model-to-investigate-multiple-skin-disorders
#35
JOURNAL ARTICLE
Kimberly A Arnold, Mary C Moran, Huishan Shi, Ivonne M J J van Vlijmen-Willems, Diana Rodijk-Olthuis, Jos P H Smits, Matthew G Brewer
The transmembrane protein claudin-1 is critical for formation of the epidermal barrier structure called tight junctions (TJ) and has been shown to be important in multiple disease states. These include neonatal ichthyosis and sclerosing cholangitis syndrome, atopic dermatitis and various viral infections. To develop a model to investigate the role of claudin-1 in different disease settings, we used CRISPR/Cas9 to generate human immortalized keratinocyte (KC) lines lacking claudin-1 (CLDN1 KO). We then determined whether loss of claudin-1 expression affects epidermal barrier formation/function and KC differentiation/stratification...
May 2024: Experimental Dermatology
https://read.qxmd.com/read/38711062/flavokawain-c-inhibits-glucose-metabolism-and-tumor-angiogenesis-in-nasopharyngeal-carcinoma-by-targeting-the-hsp90b1-stat3-hk2-signaling-axis
#36
JOURNAL ARTICLE
YuQiang Hu, ChenJie Yu, LiangJun Cheng, Chang Zhong, Jun An, MingZhen Zou, Bing Liu, Xia Gao
OBJECTIVE: Over the past decade, heat shock protein 90 (HSP90) inhibitors have emerged as promising anticancer drugs in solid and hematological malignancies. Flavokawain C (FKC) is a naturally occurring chalcone that has been found to exert considerable anti-tumor efficacy by targeting multiple molecular pathways. However, the efficacy of FKC has not been studied in nasopharyngeal carcinoma (NPC). Metabolic abnormalities and uncontrolled angiogenesis are two important features of malignant tumors, and the occurrence of these two events may involve the regulation of HSP90B1...
May 6, 2024: Cancer Cell International
https://read.qxmd.com/read/38711013/the-outcomes-of-corneal-sight-rehabilitating-surgery-in-stevens-johnson-syndrome-case-series
#37
JOURNAL ARTICLE
Rongmei Peng, Miaomiao Chi, Gege Xiao, Hongqiang Qu, Zhan Shen, Yinghan Zhao, Jing Hong
PURPOSE: To summarize the outcomes of corneal sight rehabilitating surgery in Stevens-Johnson syndrome (SJS). METHODS: This is a retrospective analysis of a consecutive case series. Twenty-four eyes of 18 SJS patients were included in this study. The ocular parameters, surgical procedures, postoperative complications, and additional treatments of the cases were reviewed. RESULTS: A total of 29 corneal sight rehabilitating surgeries, which consists of 9 keratoplasties, 8 Keratolimbal allograft (KLAL) and 12 combined surgeries (keratoplasty and KLAL simultaneously) were performed on the 24 eyes...
May 6, 2024: BMC Ophthalmology
https://read.qxmd.com/read/38710904/the-expression-of-salivary-egf-vegf-endothelin-and-transferrin-in-waterpipe-and-cigarette-smokers
#38
JOURNAL ARTICLE
Mohammad S Alrashdan, Hisham Al-Shorman, Amal Bouzid, Ahmed Al-Dwairi, Melanie Alazzam, Mohammad Alqudah
The aim of this study was to evaluate the effects of two forms of tobacco smoking, cigarettes and water pipe smoking (WPS), on the expression of a panel of salivary proteins in healthy adults. Three groups of age and gender-matched participants were enrolled in the study: never-smokers, cigarette smokers and WPS (N = 55 per group). Expression of epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), endothelin and transferrin in unstimulated whole saliva was estimated using enzyme-linked immunosorbent assays...
May 6, 2024: Odontology
https://read.qxmd.com/read/38710696/retraction-note-involvement-of-autophagy-in-hypoxia-bnip3-signaling-to-promote-epidermal-keratinocyte-migration
#39
Junhui Zhang, Can Zhang, Xupin Jiang, Lingfei Li, Dongxia Zhang, Di Tang, Tiantian Yan, Qiong Zhang, Hongping Yuan, Jiezhi Jia, Jiongyu Hu, Jiaping Zhang, Yuesheng Huang
No abstract text is available yet for this article.
May 6, 2024: Cell Death & Disease
https://read.qxmd.com/read/38710512/-in-vitro-and-in-vivo-validation-of-cytotoxicity-of-targeting-human-epidermal-growth-factor-receptor-2-chimeric-antigen-receptor-t-her2-car-t-cells
#40
JOURNAL ARTICLE
Yiting Zhang, Wenjin Xi, Pengju Wang, Xiaojuan Zhao, Rui Zheng, Sixin Liang, Ruotong Meng, Bo Yan, Angang Yang
Objective To evaluate the toxicology of targeting human epidermal growth factor receptor-2 chimeric antigen receptor T (HER2-CAR-T) cells and to provide a safety basis for the clinical evaluation of HER2-CAR-T cell therapy. Methods The recombinant lentiviral vector was used to generate HER2-CAR-T cells. Soft agar colony formation assay was used to observe the colony formation of HER2-CAR-T cells, and the colony formation rate was statistically analyzed. The HER2-CAR-T cell suspension was co-incubated with rabbit red blood cell suspension, and the hemolysis of red blood cells was evaluated by direct observation and microplate reader detection...
April 2024: Xi Bao Yu Fen Zi Mian Yi Xue za Zhi, Chinese Journal of Cellular and Molecular Immunology
keyword
keyword
164651
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.